Russian medical center finishes pre-clinical trials of nasal spray coronavirus vaccine

Dark Mode

Thursday, 26 December 2024

Russian medical center finishes pre-clinical trials of nasal spray coronavirus vaccine
August 21, 2021, 3:46 am

Russian medical center finishes pre-clinical trials of nasal spray coronavirus vaccine

COVID-19-

The Russia’s Gamaleya Center’s Director Alexander Gintsburg told Russian news website the TASS, the center has completed pre-clinical trials of a nasal spray coronavirus vaccine and are ready to launch clinical trials.

He said: "There has been serious progress made in terms of the nasal spray vaccine, pre-clinical trials are over. We are ready to move on to clinical trials."

The TASS reported according to Gintsburg, the nasal spray vaccine consists of the second component of the Sputnik V vaccine.

It should be noted that the Gamaleya Center’s director said earlier that clinical trials could begin in late 2021 or early 2022 and the vaccine was expected to be approved in 2022.

Source: tass

Covid-19 hospitalisation rates for children in US reach highest levels ever Vladimir Putin urges the West not to interfere in Afghanistan